In hyperlipidemia, HSPA5 would contribute to lipid accumulation and metabolic dysregulation by influencing lipid metabolism-related signaling pathways including NF-κB and AMPK, as well as inflammatory responses. Here, NFKB1 is linked to hyperlipidemia.